Vitamin D2026-07

Investigating the mechanisms linking vitamin D to coronary artery disease: A mediating proteomics Mendelian randomisation study.

Xue Yanqiong, Cao Shunhua, Zhang Linxia, Chen Jiaquan et al. — Medicine

Summary

This study explored how vitamin D might protect against coronary artery disease, a serious heart condition. Using a genetic approach, researchers found that higher vitamin D levels are linked to a lower risk of this disease. They also identified specific proteins and biological pathways that could explain how vitamin D exerts these protective effects on the heart.

AI-generated summary — read the original

Key points

Higher vitamin D levels are associated with a reduced risk of coronary artery disease.
The study used genetic methods to investigate a potential cause-and-effect relationship between vitamin D and heart health.
Researchers identified specific proteins and biological pathways that may explain how vitamin D influences heart disease development.
These findings offer new insights into the biological mechanisms by which vitamin D could protect the heart.

What the study looked at

What question the study asked: This study aimed to understand if and how vitamin D might causally influence the risk of coronary artery disease (CAD), a serious heart condition. Researchers wanted to move beyond simple observations to explore if vitamin D directly impacts heart health and, if so, through what specific biological pathways it exerts its effects. How it was studied (design/participants): To investigate this, the researchers used a sophisticated genetic approach called Mendelian randomization. This method utilizes natural genetic variations that influence vitamin D levels as a proxy for vitamin D exposure, helping to infer cause-and-effect relationships rather than just associations. They analyzed large datasets of genetic information from many individuals to examine the link between genetically predicted vitamin D levels and CAD risk. Additionally, they looked at blood protein data to identify specific proteins that might act as intermediaries in this relationship. What it found: The study found that individuals with genetically higher vitamin D levels had a lower risk of developing coronary artery disease. Furthermore, the analysis identified 19 specific proteins and 59 related biological pathways in the blood that appear to mediate, or explain, how vitamin D might protect against CAD. These findings suggest that vitamin D could influence heart disease through various biological mechanisms involving these proteins and pathways, offering a more detailed understanding of this connection.

Dietary takeaway

While this study suggests a potential protective role for vitamin D against coronary artery disease by identifying specific biological mechanisms, it's important to remember that this is one study and more research is needed to confirm these findings. Maintaining adequate vitamin D levels through a balanced diet, including fortified foods like milk and cereals, fatty fish, and safe sun exposure, is generally beneficial for overall health. Always consult a healthcare professional before making significant changes to your diet or considering supplementation.

Abstract

Coronary artery disease (CAD) is a leading cause of mortality and morbidity globally, with its elevated rates of disability and death posing a significant public health concern. Vitamin D is a crucial bioactive compound involved in numerous physiological processes and has garnered considerable interest due to its potential health benefits. The association between vitamin D and CAD has been a prominent focus of scholarly investigation. However, there remains considerable debate regarding whether vitamin D confers protective effects against CAD, and the underlying mechanisms by which vitamin D influences CAD remain inadequately understood. Mendelian randomization analysis was performed using large-scale genome-wide association study data to examine the causal relationship between serum 25-hydroxyvitamin D (25(OH)D) levels and CAD. Plasma proteomics data were subsequently employed for mediation analysis, followed by enrichment analysis to identify intermediary metabolic or signaling pathways through which serum 25(OH)D may mediate the onset and progression of CAD. The Mendelian randomization analysis indicated that higher serum 25(OH)D levels were associated with a reduced risk of CAD (odds ratio [95% confidence interval]: 0.799 [0.643-0.993], P = .043). No evidence of pleiotropy (P = .949) or heterogeneity (P = .630) was observed in the results. The protein-mediated analysis identified 19 plasma proteins, including Serine/threonine-protein kinase TBK1, membrane associating domain domain-containing protein 2, and interleukin-17D, as key mediators through which reduced vitamin D levels contribute to the development of CAD. The mediation effects ranged from 4.85 to 34.49%. Following the identification of these 19 mediating proteins, 59 intermediary pathways were further pinpointed through which serum vitamin D influences CAD risk. Increased levels of 25(OH)D may reduce the risk of CAD. Further, plasma proteomics-mediated analyses have uncovered potential mechanisms through which 25(OH)D influences the development of CAD, offering a detailed framework for understanding the relationship between vitamin D deficiency and CAD progression. This provides novel evidence to support the recommendation of appropriate vitamin D supplementation as part of lifestyle guidance for CAD patients.

View on PubMed →DOI: 10.1097/MD.0000000000049798